Log in
Enquire now
‌

US Patent 8664189 RNA interference in skin indications

Patent 8664189 was granted and assigned to Rxi Pharmaceuticals Corporation on March, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Rxi Pharmaceuticals Corporation
0
Date Filed
September 22, 2009
0
Date of Patent
March 4, 2014
0
Patent Application Number
13120315
0
Patent Citations Received
‌
US Patent 12077755 Bioactive conjugates for oligonucleotide delivery
0
‌
US Patent 11702659 Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
0
‌
US Patent 11753638 Conjugated oligonucleotides
‌
US Patent 11767527 Modified oligonucleotides targeting SNPs
‌
US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
0
‌
US Patent 12024706 Modified oligonucleotides targeting SNPs
0
Patent Inventor Names
James Cardia
0
Joanne Kamens
0
Pamela A. Pavco
0
Tod M. Woolf
0
William Salomon
0
Anastasia Khvorova
0
Dmitry Samarsky
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8664189
0
Patent Primary Examiner
‌
Kimberly Chong
0

Find more entities like US Patent 8664189 RNA interference in skin indications

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.